DR. GREGORY ALLEN ELDER, M.D.
Neurology in Bronx, NY
License number
New York 151302-1
Category
Neurology
Type
Neurology
Address
Address
2
130 WEST Kingsbridge Road (3F22), Bronx, NY 10468
182 E 95Th St, New York, NY 10128
182 E 95Th St, New York, NY 10128
Phone
(718) 584-9000
Personal information
See more information about GREGORY ALLEN ELDER at radaris.comName
Address
Phone
5719 Kings Hwy, Brooklyn, NY 11203
6 Elliot Ave, Dix Hills, NY 11746
182 E 95Th St APT 17J, New York, NY 10128
941 Kahle St, Bohemia, NY 11716
375 End Ave, New York, NY 10280
Professional information
See more information about GREGORY ALLEN ELDER at trustoria.com
Gregory Allen Elder, Bronx NY
Gregory Allen Elder, Bronx NY
Specialties:
Neurologist
Address:
130 W Kingsbridge Rd, Bronx, NY 10468
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)
Dr. Gregory A Elder, Bronx NY - MD (Doctor of Medicine)
Dr. Gregory A Elder, Bronx NY - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
James J Peters VA Neurology
130 W Kingsbridge Rd SUITE 3E16, Bronx 10468
(718) 584-9000 (Phone)
130 W Kingsbridge Rd SUITE 3E16, Bronx 10468
(718) 584-9000 (Phone)
Certifications:
Neurology, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Loyola University of Chicago / Stritch School of Medicine
Graduated: 1980
Loyola University of Chicago / Stritch School of Medicine
Graduated: 1980
Genetically Engineered Animals Containing Null Mutations In The Neurofilament Genes
Genetically Engineered Animals Containing Null Mutations In The Neurofilament Genes
US Patent:
2002015, Oct 24, 2002
Filed:
Jun 22, 1999
Appl. No.:
09/338033
Inventors:
ROBERT A. LAZZARINI - NEW YORK NY, US
GREGORY ELDER - NEW YORK NY, US
GREGORY ELDER - NEW YORK NY, US
International Classification:
A01K067/027, A01K067/033
US Classification:
800/003000, 800/012000, 800/013000, 800/014000, 800/018000, 800/021000, 800/024000, 800/025000
Abstract:
The present invention provides for genetically engineered non-human animals, including but not limited to mice, which lack one or more endogenous neurofilament gene. Human neurofilament genes may be introduced into such genetically non-human animals (referred to hereafter as “knockout animals”) to produce improved models of the physiology of human neurofilament proteins which may be used to study human neurofilament-associated neurodegenerative conditions.